Medicare Coverage Criteria:
Therapeutic Continuous Glucose Monitoring (CGM) and related supplies are covered by Medicare when all of the following coverage criteria (1 – 5) are met:
- The beneficiary has diabetes mellitus; and,
- The beneficiary is insulin-treated with multiple (three or more) daily administrations of insulin or a continuous subcutaneous insulin infusion (CSII) pump; and,
- The beneficiary’s insulin treatment regimen requires frequent adjustment by the beneficiary on the basis of BGM or CGM testing results; and,
- Within six (6) months prior to ordering the CGM the treating practioner has an in-person visit with the beneficiary to evaluate their diabetes control and determined that criteria (1-3) above are met; and,
- Every six (6) months following the initial prescription of the CGM the treating practioner has an in-person visit with the beneficiary to assess adherence to their CGM regimen and diabetes treatment plan.